These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12534403)

  • 21. High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection.
    Malaty H; el-Zimaity HM; Genta RM; Cole RA; Graham DY
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1001-4. PubMed ID: 8971301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Helicobacter pylori infection and gastric mucosal histological features of gastric ulcer patients with chronic gastritis patients.
    Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N
    World J Gastroenterol; 2005 Feb; 11(7):976-81. PubMed ID: 15742399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
    Jhala NC; McFarland MM; Brightman SA; Morale B; Rubin W; Atkinson BF
    Am J Gastroenterol; 1995 Oct; 90(10):1824-8. PubMed ID: 7572902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study.
    Milutinovic AS; Todorovic V; Milosavljevic T; Micev M; Spuran M; Drndarevic N
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):755-66. PubMed ID: 12811306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
    Kyzekové J; Arlt J; Arltová M
    Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
    Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa.
    Sanduleanu S; Jonkers D; De Bruine A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Mar; 15(3):379-88. PubMed ID: 11207513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
    De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
    J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?
    Kuipers EJ
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):187-94. PubMed ID: 16930292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
    Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
    Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Problems associated with the clinical use of proton pump inhibitors.
    Gillen D; McColl KE
    Pharmacol Toxicol; 2001 Dec; 89(6):281-6. PubMed ID: 11903952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy.
    Chen W; Shu D; Wilson IR; Tie A; Chadwick VS
    J Gastroenterol Hepatol; 1999 Apr; 14(4):322-7. PubMed ID: 10207780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens.
    Giannini E; Romagnoli P; Fasoli A; Chiarbonello B; Malfatti F; Botta F; Risso D; Lantieri PB; Savarino V; Testa R
    Am J Gastroenterol; 2000 Oct; 95(10):2762-7. PubMed ID: 11051345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin C inhibits corpus gastritis in Helicobacter pylori-infected patients during acid-suppressive therapy.
    Yoshinaga M; Ohtani A; Harada N; Fukuda Y; Nawata H
    J Gastroenterol Hepatol; 2001 Nov; 16(11):1206-10. PubMed ID: 11903736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
    Stack WA; Knifton A; Thirlwell D; Cockayne A; Jenkins D; Hawkey CJ; Atherton JC
    Am J Gastroenterol; 1998 Oct; 93(10):1909-13. PubMed ID: 9772054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.
    Eissele R; Brunner G; Simon B; Solcia E; Arnold R
    Gastroenterology; 1997 Mar; 112(3):707-17. PubMed ID: 9041231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged use of proton pump inhibitors, CagA status, and the outcome of Helicobacter pylori gastritis.
    Gudlaugsdottir S; van Dekken H; Stijnen T; Wilson JH
    J Clin Gastroenterol; 2002; 34(5):536-40. PubMed ID: 11960065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.